Single transcript for ACMG, and more!

Posted by Tomas Kucera on Aug 27, 2019 5:07:38 PM

We are proud to present the latest version of VarSome.com with the following new features and improvements.

gnomad 2.1.1 and Genomics Data Commons now available on VarSome!

Posted by Tomas Kucera on Jun 26, 2019 5:16:06 PM

VarSome team is proud to present the latest version of the free VarSome.com with a number of new features and improvements.

Saphetor Portal became VarSome Clinical!

Posted by Tomas Kucera on Feb 4, 2019 1:21:22 PM

The Saphetor Portal has been updated to version 7 as of February 2nd 2019 under the new name VarSome Clinical. There are many changes since version 6, and this release brings our clinical platform up to date with the features, databases and classification visible in the free VarSome.com. Our clinical platform has been on the market since 2015 and is already being used by dozens of institutional clients, such as diagnostic laboratories, hospitals, and universities from countries all over the world.

PMKB now available on VarSome!

Posted by Tomas Kucera on Jan 10, 2019 2:22:41 PM

New York and Lausanne, Switzerland - January 10, 2019 - Saphetor SA, the creator of VarSome, announced today a partnership with the Englander Institute for Precision Medicine at Weill Cornell Medicine, the creator of Precision Medicine Knowledgebase (PMKB), a curated resource for the clinical interpretation of cancer variants [1]. PMKB is now a fundamental component of VarSome’s portfolio of over 30 integrated and cross-referenced public data resources as well as VarSome’s implementation of the American College of Medical Genetics guidelines.

Introducing VarSome Pro!

Posted by Tomas Kucera on Jan 8, 2019 12:38:09 PM

We are delighted to release VarSome Pro, the advanced variant analysis platform, dramatically extending the popular VarSome platform as previously announced.

VarSome 6.7 has been released

Posted by Richard Meyer on Dec 13, 2018 2:49:50 PM

VarSome thriving community will soon reach 100,000 users, a significant milestone, and we’d like to thank you for your continuous use of the platform.